Pharma & Healthcare
Global Metaxalone Market Research Report 2024
- Feb 19, 24
- ID: 52700
- Pages: 94
- Figures: 203
- Views: 17
Metaxalone is a white, odourless crystalline powder used to relax muscles and relieve pain that could have occurred due to strain, sprain, and other musculoskeletal conditions. It has sedative and skeletal muscle relaxant effect on the body and helps relieve pain. The compound is freely soluble in chloroform; however insoluble in ether or water.
The global Metaxalone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metaxalone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metaxalone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Metaxalone include Biosynth, Chunghwa Chemical Synthesis and Biotech, Sigma-Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry and Biocore, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metaxalone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metaxalone.
Report Scope
The Metaxalone market size, estimations, and forecasts are provided in terms of sales volume (K Piece) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metaxalone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metaxalone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biosynth
Chunghwa Chemical Synthesis and Biotech
Sigma-Aldrich
CDI Technology
Angelini
Pfizer
Aurum Pharmatech
Finetech Industry
Biocore
Oxchem Corporation
Segment by Type
Bone Pain
Muscle Pain
Joint Pain
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metaxalone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metaxalone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Metaxalone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metaxalone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metaxalone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Metaxalone include Biosynth, Chunghwa Chemical Synthesis and Biotech, Sigma-Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry and Biocore, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metaxalone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metaxalone.
Report Scope
The Metaxalone market size, estimations, and forecasts are provided in terms of sales volume (K Piece) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metaxalone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metaxalone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biosynth
Chunghwa Chemical Synthesis and Biotech
Sigma-Aldrich
CDI Technology
Angelini
Pfizer
Aurum Pharmatech
Finetech Industry
Biocore
Oxchem Corporation
Segment by Type
Bone Pain
Muscle Pain
Joint Pain
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metaxalone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metaxalone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Metaxalone Market Overview
1.1 Product Overview and Scope of Metaxalone
1.2 Metaxalone Segment by Type
1.2.1 Global Metaxalone Market Value Comparison by Type (2024-2030)
1.2.2 Bone Pain
1.2.3 Muscle Pain
1.2.4 Joint Pain
1.2.5 Others
1.3 Metaxalone Segment by Application
1.3.1 Global Metaxalone Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Metaxalone Market Size Estimates and Forecasts
1.4.1 Global Metaxalone Revenue 2019-2030
1.4.2 Global Metaxalone Sales 2019-2030
1.4.3 Global Metaxalone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Metaxalone Market Competition by Manufacturers
2.1 Global Metaxalone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Metaxalone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Metaxalone Average Price by Manufacturers (2019-2024)
2.4 Global Metaxalone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metaxalone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metaxalone, Product Type & Application
2.7 Metaxalone Market Competitive Situation and Trends
2.7.1 Metaxalone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metaxalone Players Market Share by Revenue
2.7.3 Global Metaxalone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metaxalone Retrospective Market Scenario by Region
3.1 Global Metaxalone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Metaxalone Global Metaxalone Sales by Region: 2019-2030
3.2.1 Global Metaxalone Sales by Region: 2019-2024
3.2.2 Global Metaxalone Sales by Region: 2025-2030
3.3 Global Metaxalone Global Metaxalone Revenue by Region: 2019-2030
3.3.1 Global Metaxalone Revenue by Region: 2019-2024
3.3.2 Global Metaxalone Revenue by Region: 2025-2030
3.4 North America Metaxalone Market Facts & Figures by Country
3.4.1 North America Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Metaxalone Sales by Country (2019-2030)
3.4.3 North America Metaxalone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metaxalone Market Facts & Figures by Country
3.5.1 Europe Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Metaxalone Sales by Country (2019-2030)
3.5.3 Europe Metaxalone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metaxalone Market Facts & Figures by Country
3.6.1 Asia Pacific Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Metaxalone Sales by Country (2019-2030)
3.6.3 Asia Pacific Metaxalone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Metaxalone Market Facts & Figures by Country
3.7.1 Latin America Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Metaxalone Sales by Country (2019-2030)
3.7.3 Latin America Metaxalone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metaxalone Market Facts & Figures by Country
3.8.1 Middle East and Africa Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Metaxalone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Metaxalone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Metaxalone Sales by Type (2019-2030)
4.1.1 Global Metaxalone Sales by Type (2019-2024)
4.1.2 Global Metaxalone Sales by Type (2025-2030)
4.1.3 Global Metaxalone Sales Market Share by Type (2019-2030)
4.2 Global Metaxalone Revenue by Type (2019-2030)
4.2.1 Global Metaxalone Revenue by Type (2019-2024)
4.2.2 Global Metaxalone Revenue by Type (2025-2030)
4.2.3 Global Metaxalone Revenue Market Share by Type (2019-2030)
4.3 Global Metaxalone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Metaxalone Sales by Application (2019-2030)
5.1.1 Global Metaxalone Sales by Application (2019-2024)
5.1.2 Global Metaxalone Sales by Application (2025-2030)
5.1.3 Global Metaxalone Sales Market Share by Application (2019-2030)
5.2 Global Metaxalone Revenue by Application (2019-2030)
5.2.1 Global Metaxalone Revenue by Application (2019-2024)
5.2.2 Global Metaxalone Revenue by Application (2025-2030)
5.2.3 Global Metaxalone Revenue Market Share by Application (2019-2030)
5.3 Global Metaxalone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biosynth
6.1.1 Biosynth Corporation Information
6.1.2 Biosynth Description and Business Overview
6.1.3 Biosynth Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biosynth Metaxalone Product Portfolio
6.1.5 Biosynth Recent Developments/Updates
6.2 Chunghwa Chemical Synthesis and Biotech
6.2.1 Chunghwa Chemical Synthesis and Biotech Corporation Information
6.2.2 Chunghwa Chemical Synthesis and Biotech Description and Business Overview
6.2.3 Chunghwa Chemical Synthesis and Biotech Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chunghwa Chemical Synthesis and Biotech Metaxalone Product Portfolio
6.2.5 Chunghwa Chemical Synthesis and Biotech Recent Developments/Updates
6.3 Sigma-Aldrich
6.3.1 Sigma-Aldrich Corporation Information
6.3.2 Sigma-Aldrich Description and Business Overview
6.3.3 Sigma-Aldrich Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sigma-Aldrich Metaxalone Product Portfolio
6.3.5 Sigma-Aldrich Recent Developments/Updates
6.4 CDI Technology
6.4.1 CDI Technology Corporation Information
6.4.2 CDI Technology Description and Business Overview
6.4.3 CDI Technology Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CDI Technology Metaxalone Product Portfolio
6.4.5 CDI Technology Recent Developments/Updates
6.5 Angelini
6.5.1 Angelini Corporation Information
6.5.2 Angelini Description and Business Overview
6.5.3 Angelini Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Angelini Metaxalone Product Portfolio
6.5.5 Angelini Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Metaxalone Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Aurum Pharmatech
6.6.1 Aurum Pharmatech Corporation Information
6.6.2 Aurum Pharmatech Description and Business Overview
6.6.3 Aurum Pharmatech Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurum Pharmatech Metaxalone Product Portfolio
6.7.5 Aurum Pharmatech Recent Developments/Updates
6.8 Finetech Industry
6.8.1 Finetech Industry Corporation Information
6.8.2 Finetech Industry Description and Business Overview
6.8.3 Finetech Industry Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Finetech Industry Metaxalone Product Portfolio
6.8.5 Finetech Industry Recent Developments/Updates
6.9 Biocore
6.9.1 Biocore Corporation Information
6.9.2 Biocore Description and Business Overview
6.9.3 Biocore Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biocore Metaxalone Product Portfolio
6.9.5 Biocore Recent Developments/Updates
6.10 Oxchem Corporation
6.10.1 Oxchem Corporation Corporation Information
6.10.2 Oxchem Corporation Description and Business Overview
6.10.3 Oxchem Corporation Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Oxchem Corporation Metaxalone Product Portfolio
6.10.5 Oxchem Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metaxalone Industry Chain Analysis
7.2 Metaxalone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metaxalone Production Mode & Process
7.4 Metaxalone Sales and Marketing
7.4.1 Metaxalone Sales Channels
7.4.2 Metaxalone Distributors
7.5 Metaxalone Customers
8 Metaxalone Market Dynamics
8.1 Metaxalone Industry Trends
8.2 Metaxalone Market Drivers
8.3 Metaxalone Market Challenges
8.4 Metaxalone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Metaxalone
1.2 Metaxalone Segment by Type
1.2.1 Global Metaxalone Market Value Comparison by Type (2024-2030)
1.2.2 Bone Pain
1.2.3 Muscle Pain
1.2.4 Joint Pain
1.2.5 Others
1.3 Metaxalone Segment by Application
1.3.1 Global Metaxalone Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Metaxalone Market Size Estimates and Forecasts
1.4.1 Global Metaxalone Revenue 2019-2030
1.4.2 Global Metaxalone Sales 2019-2030
1.4.3 Global Metaxalone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Metaxalone Market Competition by Manufacturers
2.1 Global Metaxalone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Metaxalone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Metaxalone Average Price by Manufacturers (2019-2024)
2.4 Global Metaxalone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metaxalone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metaxalone, Product Type & Application
2.7 Metaxalone Market Competitive Situation and Trends
2.7.1 Metaxalone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metaxalone Players Market Share by Revenue
2.7.3 Global Metaxalone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metaxalone Retrospective Market Scenario by Region
3.1 Global Metaxalone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Metaxalone Global Metaxalone Sales by Region: 2019-2030
3.2.1 Global Metaxalone Sales by Region: 2019-2024
3.2.2 Global Metaxalone Sales by Region: 2025-2030
3.3 Global Metaxalone Global Metaxalone Revenue by Region: 2019-2030
3.3.1 Global Metaxalone Revenue by Region: 2019-2024
3.3.2 Global Metaxalone Revenue by Region: 2025-2030
3.4 North America Metaxalone Market Facts & Figures by Country
3.4.1 North America Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Metaxalone Sales by Country (2019-2030)
3.4.3 North America Metaxalone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metaxalone Market Facts & Figures by Country
3.5.1 Europe Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Metaxalone Sales by Country (2019-2030)
3.5.3 Europe Metaxalone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metaxalone Market Facts & Figures by Country
3.6.1 Asia Pacific Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Metaxalone Sales by Country (2019-2030)
3.6.3 Asia Pacific Metaxalone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Metaxalone Market Facts & Figures by Country
3.7.1 Latin America Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Metaxalone Sales by Country (2019-2030)
3.7.3 Latin America Metaxalone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metaxalone Market Facts & Figures by Country
3.8.1 Middle East and Africa Metaxalone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Metaxalone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Metaxalone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Metaxalone Sales by Type (2019-2030)
4.1.1 Global Metaxalone Sales by Type (2019-2024)
4.1.2 Global Metaxalone Sales by Type (2025-2030)
4.1.3 Global Metaxalone Sales Market Share by Type (2019-2030)
4.2 Global Metaxalone Revenue by Type (2019-2030)
4.2.1 Global Metaxalone Revenue by Type (2019-2024)
4.2.2 Global Metaxalone Revenue by Type (2025-2030)
4.2.3 Global Metaxalone Revenue Market Share by Type (2019-2030)
4.3 Global Metaxalone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Metaxalone Sales by Application (2019-2030)
5.1.1 Global Metaxalone Sales by Application (2019-2024)
5.1.2 Global Metaxalone Sales by Application (2025-2030)
5.1.3 Global Metaxalone Sales Market Share by Application (2019-2030)
5.2 Global Metaxalone Revenue by Application (2019-2030)
5.2.1 Global Metaxalone Revenue by Application (2019-2024)
5.2.2 Global Metaxalone Revenue by Application (2025-2030)
5.2.3 Global Metaxalone Revenue Market Share by Application (2019-2030)
5.3 Global Metaxalone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biosynth
6.1.1 Biosynth Corporation Information
6.1.2 Biosynth Description and Business Overview
6.1.3 Biosynth Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biosynth Metaxalone Product Portfolio
6.1.5 Biosynth Recent Developments/Updates
6.2 Chunghwa Chemical Synthesis and Biotech
6.2.1 Chunghwa Chemical Synthesis and Biotech Corporation Information
6.2.2 Chunghwa Chemical Synthesis and Biotech Description and Business Overview
6.2.3 Chunghwa Chemical Synthesis and Biotech Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chunghwa Chemical Synthesis and Biotech Metaxalone Product Portfolio
6.2.5 Chunghwa Chemical Synthesis and Biotech Recent Developments/Updates
6.3 Sigma-Aldrich
6.3.1 Sigma-Aldrich Corporation Information
6.3.2 Sigma-Aldrich Description and Business Overview
6.3.3 Sigma-Aldrich Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sigma-Aldrich Metaxalone Product Portfolio
6.3.5 Sigma-Aldrich Recent Developments/Updates
6.4 CDI Technology
6.4.1 CDI Technology Corporation Information
6.4.2 CDI Technology Description and Business Overview
6.4.3 CDI Technology Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CDI Technology Metaxalone Product Portfolio
6.4.5 CDI Technology Recent Developments/Updates
6.5 Angelini
6.5.1 Angelini Corporation Information
6.5.2 Angelini Description and Business Overview
6.5.3 Angelini Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Angelini Metaxalone Product Portfolio
6.5.5 Angelini Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Metaxalone Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Aurum Pharmatech
6.6.1 Aurum Pharmatech Corporation Information
6.6.2 Aurum Pharmatech Description and Business Overview
6.6.3 Aurum Pharmatech Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurum Pharmatech Metaxalone Product Portfolio
6.7.5 Aurum Pharmatech Recent Developments/Updates
6.8 Finetech Industry
6.8.1 Finetech Industry Corporation Information
6.8.2 Finetech Industry Description and Business Overview
6.8.3 Finetech Industry Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Finetech Industry Metaxalone Product Portfolio
6.8.5 Finetech Industry Recent Developments/Updates
6.9 Biocore
6.9.1 Biocore Corporation Information
6.9.2 Biocore Description and Business Overview
6.9.3 Biocore Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biocore Metaxalone Product Portfolio
6.9.5 Biocore Recent Developments/Updates
6.10 Oxchem Corporation
6.10.1 Oxchem Corporation Corporation Information
6.10.2 Oxchem Corporation Description and Business Overview
6.10.3 Oxchem Corporation Metaxalone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Oxchem Corporation Metaxalone Product Portfolio
6.10.5 Oxchem Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metaxalone Industry Chain Analysis
7.2 Metaxalone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metaxalone Production Mode & Process
7.4 Metaxalone Sales and Marketing
7.4.1 Metaxalone Sales Channels
7.4.2 Metaxalone Distributors
7.5 Metaxalone Customers
8 Metaxalone Market Dynamics
8.1 Metaxalone Industry Trends
8.2 Metaxalone Market Drivers
8.3 Metaxalone Market Challenges
8.4 Metaxalone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Metaxalone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Metaxalone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Metaxalone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Metaxalone Sales (K Piece) of Key Manufacturers (2019-2024)
Table 5. Global Metaxalone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Metaxalone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Metaxalone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Metaxalone Average Price (USD/Piece) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Metaxalone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metaxalone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metaxalone, Product Type & Application
Table 12. Global Key Manufacturers of Metaxalone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metaxalone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metaxalone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metaxalone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Metaxalone Sales by Region (2019-2024) & (K Piece)
Table 18. Global Metaxalone Sales Market Share by Region (2019-2024)
Table 19. Global Metaxalone Sales by Region (2025-2030) & (K Piece)
Table 20. Global Metaxalone Sales Market Share by Region (2025-2030)
Table 21. Global Metaxalone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Metaxalone Revenue Market Share by Region (2019-2024)
Table 23. Global Metaxalone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Metaxalone Revenue Market Share by Region (2025-2030)
Table 25. North America Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 27. North America Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 28. North America Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 32. Europe Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 33. Europe Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Metaxalone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Metaxalone Sales by Region (2019-2024) & (K Piece)
Table 37. Asia Pacific Metaxalone Sales by Region (2025-2030) & (K Piece)
Table 38. Asia Pacific Metaxalone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Metaxalone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 42. Latin America Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 43. Latin America Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 47. Middle East & Africa Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 48. Middle East & Africa Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Metaxalone Sales (K Piece) by Type (2019-2024)
Table 51. Global Metaxalone Sales (K Piece) by Type (2025-2030)
Table 52. Global Metaxalone Sales Market Share by Type (2019-2024)
Table 53. Global Metaxalone Sales Market Share by Type (2025-2030)
Table 54. Global Metaxalone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Metaxalone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Metaxalone Revenue Market Share by Type (2019-2024)
Table 57. Global Metaxalone Revenue Market Share by Type (2025-2030)
Table 58. Global Metaxalone Price (USD/Piece) by Type (2019-2024)
Table 59. Global Metaxalone Price (USD/Piece) by Type (2025-2030)
Table 60. Global Metaxalone Sales (K Piece) by Application (2019-2024)
Table 61. Global Metaxalone Sales (K Piece) by Application (2025-2030)
Table 62. Global Metaxalone Sales Market Share by Application (2019-2024)
Table 63. Global Metaxalone Sales Market Share by Application (2025-2030)
Table 64. Global Metaxalone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Metaxalone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Metaxalone Revenue Market Share by Application (2019-2024)
Table 67. Global Metaxalone Revenue Market Share by Application (2025-2030)
Table 68. Global Metaxalone Price (USD/Piece) by Application (2019-2024)
Table 69. Global Metaxalone Price (USD/Piece) by Application (2025-2030)
Table 70. Biosynth Corporation Information
Table 71. Biosynth Description and Business Overview
Table 72. Biosynth Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 73. Biosynth Metaxalone Product
Table 74. Biosynth Recent Developments/Updates
Table 75. Chunghwa Chemical Synthesis and Biotech Corporation Information
Table 76. Chunghwa Chemical Synthesis and Biotech Description and Business Overview
Table 77. Chunghwa Chemical Synthesis and Biotech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 78. Chunghwa Chemical Synthesis and Biotech Metaxalone Product
Table 79. Chunghwa Chemical Synthesis and Biotech Recent Developments/Updates
Table 80. Sigma-Aldrich Corporation Information
Table 81. Sigma-Aldrich Description and Business Overview
Table 82. Sigma-Aldrich Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 83. Sigma-Aldrich Metaxalone Product
Table 84. Sigma-Aldrich Recent Developments/Updates
Table 85. CDI Technology Corporation Information
Table 86. CDI Technology Description and Business Overview
Table 87. CDI Technology Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 88. CDI Technology Metaxalone Product
Table 89. CDI Technology Recent Developments/Updates
Table 90. Angelini Corporation Information
Table 91. Angelini Description and Business Overview
Table 92. Angelini Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 93. Angelini Metaxalone Product
Table 94. Angelini Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 98. Pfizer Metaxalone Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Aurum Pharmatech Corporation Information
Table 101. Aurum Pharmatech Description and Business Overview
Table 102. Aurum Pharmatech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 103. Aurum Pharmatech Metaxalone Product
Table 104. Aurum Pharmatech Recent Developments/Updates
Table 105. Finetech Industry Corporation Information
Table 106. Finetech Industry Description and Business Overview
Table 107. Finetech Industry Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 108. Finetech Industry Metaxalone Product
Table 109. Finetech Industry Recent Developments/Updates
Table 110. Biocore Corporation Information
Table 111. Biocore Description and Business Overview
Table 112. Biocore Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 113. Biocore Metaxalone Product
Table 114. Biocore Recent Developments/Updates
Table 115. Oxchem Corporation Corporation Information
Table 116. Oxchem Corporation Description and Business Overview
Table 117. Oxchem Corporation Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 118. Oxchem Corporation Metaxalone Product
Table 119. Oxchem Corporation Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Metaxalone Distributors List
Table 123. Metaxalone Customers List
Table 124. Metaxalone Market Trends
Table 125. Metaxalone Market Drivers
Table 126. Metaxalone Market Challenges
Table 127. Metaxalone Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metaxalone
Figure 2. Global Metaxalone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Metaxalone Market Share by Type in 2023 & 2030
Figure 4. Bone Pain Product Picture
Figure 5. Muscle Pain Product Picture
Figure 6. Joint Pain Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metaxalone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Metaxalone Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Metaxalone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Metaxalone Market Size (2019-2030) & (US$ Million)
Figure 15. Global Metaxalone Sales (2019-2030) & (K Piece)
Figure 16. Global Metaxalone Average Price (USD/Piece) & (2019-2030)
Figure 17. Metaxalone Report Years Considered
Figure 18. Metaxalone Sales Share by Manufacturers in 2023
Figure 19. Global Metaxalone Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Metaxalone Players: Market Share by Revenue in 2023
Figure 21. Metaxalone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Metaxalone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Metaxalone Sales Market Share by Country (2019-2030)
Figure 24. North America Metaxalone Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Metaxalone Sales Market Share by Country (2019-2030)
Figure 28. Europe Metaxalone Revenue Market Share by Country (2019-2030)
Figure 29. Germany Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Metaxalone Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Metaxalone Revenue Market Share by Region (2019-2030)
Figure 36. China Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Metaxalone Sales Market Share by Country (2019-2030)
Figure 47. Latin America Metaxalone Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Metaxalone Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Metaxalone Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Metaxalone by Type (2019-2030)
Figure 57. Global Revenue Market Share of Metaxalone by Type (2019-2030)
Figure 58. Global Metaxalone Price (USD/Piece) by Type (2019-2030)
Figure 59. Global Sales Market Share of Metaxalone by Application (2019-2030)
Figure 60. Global Revenue Market Share of Metaxalone by Application (2019-2030)
Figure 61. Global Metaxalone Price (USD/Piece) by Application (2019-2030)
Figure 62. Metaxalone Value Chain
Figure 63. Metaxalone Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Metaxalone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Metaxalone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Metaxalone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Metaxalone Sales (K Piece) of Key Manufacturers (2019-2024)
Table 5. Global Metaxalone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Metaxalone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Metaxalone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Metaxalone Average Price (USD/Piece) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Metaxalone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metaxalone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metaxalone, Product Type & Application
Table 12. Global Key Manufacturers of Metaxalone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metaxalone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metaxalone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metaxalone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Metaxalone Sales by Region (2019-2024) & (K Piece)
Table 18. Global Metaxalone Sales Market Share by Region (2019-2024)
Table 19. Global Metaxalone Sales by Region (2025-2030) & (K Piece)
Table 20. Global Metaxalone Sales Market Share by Region (2025-2030)
Table 21. Global Metaxalone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Metaxalone Revenue Market Share by Region (2019-2024)
Table 23. Global Metaxalone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Metaxalone Revenue Market Share by Region (2025-2030)
Table 25. North America Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 27. North America Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 28. North America Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 32. Europe Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 33. Europe Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Metaxalone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Metaxalone Sales by Region (2019-2024) & (K Piece)
Table 37. Asia Pacific Metaxalone Sales by Region (2025-2030) & (K Piece)
Table 38. Asia Pacific Metaxalone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Metaxalone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 42. Latin America Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 43. Latin America Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Metaxalone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Metaxalone Sales by Country (2019-2024) & (K Piece)
Table 47. Middle East & Africa Metaxalone Sales by Country (2025-2030) & (K Piece)
Table 48. Middle East & Africa Metaxalone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Metaxalone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Metaxalone Sales (K Piece) by Type (2019-2024)
Table 51. Global Metaxalone Sales (K Piece) by Type (2025-2030)
Table 52. Global Metaxalone Sales Market Share by Type (2019-2024)
Table 53. Global Metaxalone Sales Market Share by Type (2025-2030)
Table 54. Global Metaxalone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Metaxalone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Metaxalone Revenue Market Share by Type (2019-2024)
Table 57. Global Metaxalone Revenue Market Share by Type (2025-2030)
Table 58. Global Metaxalone Price (USD/Piece) by Type (2019-2024)
Table 59. Global Metaxalone Price (USD/Piece) by Type (2025-2030)
Table 60. Global Metaxalone Sales (K Piece) by Application (2019-2024)
Table 61. Global Metaxalone Sales (K Piece) by Application (2025-2030)
Table 62. Global Metaxalone Sales Market Share by Application (2019-2024)
Table 63. Global Metaxalone Sales Market Share by Application (2025-2030)
Table 64. Global Metaxalone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Metaxalone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Metaxalone Revenue Market Share by Application (2019-2024)
Table 67. Global Metaxalone Revenue Market Share by Application (2025-2030)
Table 68. Global Metaxalone Price (USD/Piece) by Application (2019-2024)
Table 69. Global Metaxalone Price (USD/Piece) by Application (2025-2030)
Table 70. Biosynth Corporation Information
Table 71. Biosynth Description and Business Overview
Table 72. Biosynth Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 73. Biosynth Metaxalone Product
Table 74. Biosynth Recent Developments/Updates
Table 75. Chunghwa Chemical Synthesis and Biotech Corporation Information
Table 76. Chunghwa Chemical Synthesis and Biotech Description and Business Overview
Table 77. Chunghwa Chemical Synthesis and Biotech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 78. Chunghwa Chemical Synthesis and Biotech Metaxalone Product
Table 79. Chunghwa Chemical Synthesis and Biotech Recent Developments/Updates
Table 80. Sigma-Aldrich Corporation Information
Table 81. Sigma-Aldrich Description and Business Overview
Table 82. Sigma-Aldrich Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 83. Sigma-Aldrich Metaxalone Product
Table 84. Sigma-Aldrich Recent Developments/Updates
Table 85. CDI Technology Corporation Information
Table 86. CDI Technology Description and Business Overview
Table 87. CDI Technology Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 88. CDI Technology Metaxalone Product
Table 89. CDI Technology Recent Developments/Updates
Table 90. Angelini Corporation Information
Table 91. Angelini Description and Business Overview
Table 92. Angelini Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 93. Angelini Metaxalone Product
Table 94. Angelini Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 98. Pfizer Metaxalone Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Aurum Pharmatech Corporation Information
Table 101. Aurum Pharmatech Description and Business Overview
Table 102. Aurum Pharmatech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 103. Aurum Pharmatech Metaxalone Product
Table 104. Aurum Pharmatech Recent Developments/Updates
Table 105. Finetech Industry Corporation Information
Table 106. Finetech Industry Description and Business Overview
Table 107. Finetech Industry Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 108. Finetech Industry Metaxalone Product
Table 109. Finetech Industry Recent Developments/Updates
Table 110. Biocore Corporation Information
Table 111. Biocore Description and Business Overview
Table 112. Biocore Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 113. Biocore Metaxalone Product
Table 114. Biocore Recent Developments/Updates
Table 115. Oxchem Corporation Corporation Information
Table 116. Oxchem Corporation Description and Business Overview
Table 117. Oxchem Corporation Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 118. Oxchem Corporation Metaxalone Product
Table 119. Oxchem Corporation Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Metaxalone Distributors List
Table 123. Metaxalone Customers List
Table 124. Metaxalone Market Trends
Table 125. Metaxalone Market Drivers
Table 126. Metaxalone Market Challenges
Table 127. Metaxalone Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metaxalone
Figure 2. Global Metaxalone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Metaxalone Market Share by Type in 2023 & 2030
Figure 4. Bone Pain Product Picture
Figure 5. Muscle Pain Product Picture
Figure 6. Joint Pain Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metaxalone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Metaxalone Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Metaxalone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Metaxalone Market Size (2019-2030) & (US$ Million)
Figure 15. Global Metaxalone Sales (2019-2030) & (K Piece)
Figure 16. Global Metaxalone Average Price (USD/Piece) & (2019-2030)
Figure 17. Metaxalone Report Years Considered
Figure 18. Metaxalone Sales Share by Manufacturers in 2023
Figure 19. Global Metaxalone Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Metaxalone Players: Market Share by Revenue in 2023
Figure 21. Metaxalone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Metaxalone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Metaxalone Sales Market Share by Country (2019-2030)
Figure 24. North America Metaxalone Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Metaxalone Sales Market Share by Country (2019-2030)
Figure 28. Europe Metaxalone Revenue Market Share by Country (2019-2030)
Figure 29. Germany Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Metaxalone Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Metaxalone Revenue Market Share by Region (2019-2030)
Figure 36. China Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Metaxalone Sales Market Share by Country (2019-2030)
Figure 47. Latin America Metaxalone Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Metaxalone Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Metaxalone Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Metaxalone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Metaxalone by Type (2019-2030)
Figure 57. Global Revenue Market Share of Metaxalone by Type (2019-2030)
Figure 58. Global Metaxalone Price (USD/Piece) by Type (2019-2030)
Figure 59. Global Sales Market Share of Metaxalone by Application (2019-2030)
Figure 60. Global Revenue Market Share of Metaxalone by Application (2019-2030)
Figure 61. Global Metaxalone Price (USD/Piece) by Application (2019-2030)
Figure 62. Metaxalone Value Chain
Figure 63. Metaxalone Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232